文献速递血液净化与透析急性肾损伤

中毒及其他急诊适应症的体外治疗可及性与成本:一项全球调查

Availability and cost of extracorporeal treatments for poisonings and other emergency indications: a worldwide survey.
PubMed 文献 · Nephrol Dial Transplant · 2017-01-01

该调查于2014年1月至2015年3月通过电子邮件向国际学会成员发放网络问卷,评估体外治疗(ECTR)的可及性、启动时间和成本。162名来自89个国家的受访者提供充分数据;间歇性血液透析(IHD)可及性最高(96.9%),启动时间中位数60分钟,成本至少比其他ECTR低30%。作者认为IHD是急性中毒大多数情况下的首选ECTR。

要点

  • IHD是急性ECTR中可及性最高的方式(96.9%),其次为治疗性血浆置换(68.3%)和连续性肾脏替代治疗(62.9%)。
  • IHD、CRRT和血液灌流的启动时间中位数最短(60分钟)。
  • 与IHD相比的成本比中位数:CRRT和血液灌流为1.7,治疗性血浆置换为2.8,肝支持装置为6.5,腹膜透析为1.4(均P<0.001)。

核心结论

  • IHD似乎是全球可及性最广的ECTR,且至少比其他ECTR便宜30%。
  • IHD在增强清除方面疗效更优,加上成本更低、可及性更广,强化了其作为大多数急性中毒首选ECTR的地位。

研究设计与样本

  • 通过电子邮件向国际学会成员发放网络问卷的全球调查,调查时间为2014年1月至2015年3月。
  • 问卷用于确定ECTR的可及性、启动时间和成本(包括滤器、透析液、导管、抗凝剂及护理/医生薪资)。
  • 受访者来自89个国家,近四分之三在三级护理中心执业;162名受访者提供充分数据用于深度分析。

主要发现

  • IHD是最可及的急性ECTR(96.9%),其次为治疗性血浆置换(68.3%)、连续性肾脏替代治疗(62.9%)、腹膜透析(44.8%)、血液灌流(30.9%)和肝支持装置(14.7%)。
  • IHD、CRRT和血液灌流的启动时间中位数最短(60分钟)。
  • 与IHD相比的各ECTR成本比中位数:CRRT和血液灌流为1.7,治疗性血浆置换为2.8,肝支持装置为6.5,腹膜透析为1.4(均P<0.001)。
  • 4小时IHD治疗与重症监护病房1天相比的成本比中位数为0.6(P=0.2)。

关键数值与推荐

  • IHD可及性96.9%,治疗性血浆置换68.3%,CRRT 62.9%,腹膜透析44.8%,血液灌流30.9%,肝支持装置14.7%。
  • IHD、CRRT和血液灌流启动时间中位数均为60分钟。
  • 与IHD相比的成本比中位数:CRRT 1.7,血液灌流1.7,治疗性血浆置换2.8,肝支持装置6.5,腹膜透析1.4(均P<0.001)。
  • 4小时IHD治疗与ICU 1天相比的成本比中位数为0.6(P=0.2)。

临床怎么用

  • 原文结论指出,IHD在增强清除方面疗效更优、成本更低且可及性更广,强化了其作为大多数急性中毒首选ECTR的地位。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Extracorporeal treatments (ECTRs) are used for different conditions, including replacement of organ function and poisoning. Current recommendations for ECTRs in various poisonings suggest that intermittent haemodialysis (IHD) is the most efficient technique. However, the practicality of these recommendations is poorly defined in view of limited information on availability and cost worldwide. METHODS: A survey invitation to an Internet-based questionnaire was emailed between January 2014 and March 2015 to members of international societies to determine the availability, time to initiation and cost of ECTRs (including filters, dialysate, catheter, anticoagulant and nursing/physician salary). The median cost ratio of every ECTR compared with IHD performed in the same institution were presented. RESULTS: The view rate was estimated at 28.1% (2532/9000), the participation rate was 40.1% (1015/2532) and the completion rate was 16.0% (162/1015). Respondents originated from 89 countries, and nearly three-fourths practiced in a tertiary care centre. A total of 162 respondents provided sufficient data for in-depth analysis. IHD was the most available acute ECTR (96.9%), followed by therapeutic plasma exchange (TPE; 68.3%), continuous renal replacement therapy (CRRT; 62.9%), peritoneal dialysis (PD; 44.8%), haemoperfusion (HP; 30.9%) and liver support devices (LSDs; 14.7%). IHD, CRRT and HP were the shortest to initiate (median = 60 min). The median cost ratios of each ECTR compared with IHD were 1.7 for CRRT and HP, 2.8 for TPE, 6.5 for LSDs and 1.4 for PD (P < 0.001 for all). The median cost ratio of a 4-h IHD treatment compared with 1 day in the intensive care unit was 0.6 (P = 0.2). CONCLUSIONS: IHD appears to be the most widely available ECTR worldwide and is at least 30% less expensive than other ECTRs. The superior efficacy of IHD for enhanced elimination, added to its lower cost and wider availability, strengthens its preference as the ECTR of choice in most cases of acute poisoning. KEYWORDS: costing, CRRT, EXTRIP, hemodialysis, hemoperfusion.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Bouchard J, Lavergne V, Roberts DM, et al. Availability and cost of extracorporeal treatments for poisonings and other emergency indications: a worldwide survey. Nephrol Dial Transplant. 2017. PMID: 28339843. doi:10.1093/ndt/gfw456

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。